MP-201

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMP-201
Drug Alias NameMP-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBrain-derived neurotrophic factor expression stimulantsMitochondrial proteins modulators
TargetsMitochondrial proteinsBrain-derived neurotrophic factor
Therapy Area/IndicationsOptic NeuritisParkinson DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitochon Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMitochon Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsOptic NeuritisParkinson DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A